The purpose of this application is to study the central role played by von Willebrand factor (VWF) in initiating platelet deposition at sites of vascular injury, particularly in areas of the circulation characterized by rapid blood flow. The goal is to elucidate the mechanisms of adhesive interactions and cellular responses that are relevant to the arrest of bleeding from wounded tissues but also to the development of common and serious diseases caused by arterial thrombosis, such as myocardial infarction and stroke.
The first aim i s to define the biomechanical characteristics of the bonds formed between the VWF A1 domain and the platelet glycoprotein (GP) Iba in relation to specific structural aspects of the A1 domain.
The second aim i s to define the mechanisms through which soluble VWF multimers and membrane tethers contribute to stabilizing platelet adhesion mediated by GP Iba. These studies will be relevant to understand how platelets may precipitate the acute occlusion of stenotic arteries.
The third aim i s based on the crystallographic evidence: that a-thrombin may stabilize the VWF A1 domain-GP Iba interaction, and may thus play an unexpected role in modulating the initial adhesion of platelets to a thrombogenic surface through a mechanism that is independent of platelet activation. The proposed studies will clarify the biological significance and structural bases of this novel alpha-thrombin function.
The fourth aim i s to characterize the signaling events related to the interaction between the VWF A1 domain and GP Iba, and obtain a more definitive definition of the mechanisms through which the interaction contributes to platelet activation. The fifth aim is to define how VWF binds to extracellular matrix components, in particular to define the potential biological significance of the interactions with collagen type VI and the oligosaccharides that are present in proteoglycans. The results of the proposed studies will have an impact on public health by providing novel mechanistic information on processes that are central to normal hemostasis and pathological arterial thrombosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL077436-01
Application #
6811202
Study Section
Hemostasis and Thrombosis Study Section (HT)
Program Officer
Ganguly, Pankaj
Project Start
2004-07-01
Project End
2005-02-14
Budget Start
2004-07-01
Budget End
2005-02-14
Support Year
1
Fiscal Year
2004
Total Cost
$312,828
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037